Podocyte purinergic P2X4 channels are mechanotransducers that mediate cytoskeletal disorganization

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 848-862

  Forst, Anna Lena ^a   Olteanu, Vlad Sorin ^a   Mollet, Géraldine ^b   Wlodkowski, Tanja ^c   Schaefer, Franz ^c   DIetrich, Alexander ^a   Reiser, Jochen ^d   Gudermann, Thomas ^a,e   Schnitzler, Michael Mederos ^a,e   Storch, Ursula ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b IMAGINE INSTITUTE   (France)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN II; CD2 ASSOCIATED PROTEIN; CHOLESTEROL; NEPHRIN; PODOCIN; PURINERGIC P2X4 RECEPTOR; SYNAPTOPODIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V1B RECEPTOR; VASOPRESSIN V2 RECEPTOR; 5-(3-BROMOPHENYL)-1,3-DIHYDRO-2H-BENZOFURO(3,2-E)-1,4-DIAZEPIN-2-ONE; ADENOSINE TRIPHOSPHATE; BENZODIAZEPINE DERIVATIVE; CALCIUM; MEMBRANE PROTEIN; PURINERGIC P2X RECEPTOR ANTAGONIST; SIGNAL PEPTIDE; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRPC6 PROTEIN, MOUSE;

ACTIN FILAMENT; ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EXOCYTOSIS; FLUOROMETRY; GENE INACTIVATION; MECHANICAL STIMULATION; MECHANOTRANSDUCTION; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOSKELETON; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZODIAZEPINONES; CALCIUM; CELLS, CULTURED; CHOLESTEROL; CYTOSKELETON; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MECHANOTRANSDUCTION, CELLULAR; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PODOCYTES; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X4; STRESS, MECHANICAL; TRPC CATION CHANNELS;

EID: 84959922745     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014111144     Document Type: Article

References (60)

1. Huber TB, Benzing T: The slit diaphragm: A signaling platform to regulate podocyte function. Curr Opin Nephrol Hypertens 14: 211-216, 2005
2. Huber TB, Schermer B, Benzing T: Podocin organizes ion channel-lipid supercomplexes: Implications for mechanosensation at the slit diaphragm. Nephron, Exp Nephrol 106: e27-e31, 2007
3. Endlich N, Endlich K: The challenge and response of podocytes to glomerular hypertension. Semin Nephrol 32: 327-341, 2012
4. Kreisberg JI, Karnovsky MJ: Focal glomerular sclerosis in the fawnhooded rat. Am J Pathol 92: 637-652, 1978
5. Kretzler M, Koeppen-Hagemann I, Kriz W: Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Archiv 425: 181-193, 1994
6. Kriz W, Hosser H, Hähnel B, Simons JL, Provoost AP: Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat. J AmSoc Nephrol 9: 381-396, 1998
7. Bidani AK, Griffin KA: Long-term renal consequences of hypertension for normal and diseased kidneys. CurrOpin Nephrol Hypertens 11: 73-80, 2002
8. Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C,McGeeM, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR: TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37: 739-744, 2005
9. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308: 1801-1804, 2005
10. Huber TB, Schermer B, Müller RU, Höhne M, Bartram M, Calixto A, Hagmann H, Reinhardt C, Koos F, Kunzelmann K, Shirokova E, Krautwurst D, Harteneck C, Simons M, Pavenstädt H, Kerjaschki D, Thiele C, Walz G, Chalfie M, Benzing T: Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. ProcNatl Acad Sci U S A 103: 17079-17086, 2006
11. El Hindi S, Reiser J: TRPC channel modulation in podocytes-inching toward novel treatments for glomerular disease. Pediatr Nephrol 26: 1057-1064, 2011
12. Gottlieb P, Folgering J, Maroto R, Raso A, Wood TG, Kurosky A, BowmanC, Bichet D, Patel A, Sachs F, Martinac B,HamillOP,Honore E: Revisiting TRPC1 and TRPC6 mechanosensitivity. Pflugers Archiv 455: 1097-1103, 2008
13. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K, Gollasch M, Gudermann T: Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 27: 3092-3103, 2008
14. Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Delmas P, Patel A, Honoré E: Sensing pressure in the cardiovascular system: Gq-coupled mechanoreceptors and TRP channels. J Mol Cell Cardiol 48: 83-89, 2010
15. Blodow S, Schneider H, Storch U, Wizemann R, Forst AL,Gudermann T, Mederos y Schnitzler M: Novel role of mechanosensitive AT1B receptors inmyogenic vasoconstriction. Pflugers Archiv 466: 1343-1353, 2014
16. Storch U, Mederos y Schnitzler M, Gudermann T: G protein-mediated stretch reception. Am J Physiol Heart Circ Physiol 302: H1241-H1249, 2012
17. Mederos y Schnitzler M, Storch U, Gudermann T: AT1 receptors as mechanosensors. Curr Opin Pharmacol 11: 112-116, 2011
18. Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M: Hypertension and kidneys: Unraveling complex molecular mechanisms underlying hypertensive renal damage. JHumHypertens 28: 74-79, 2014
19. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalizedmouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997
20. Dietrich A, Mederos Y Schnitzler M, Gollasch M, Gross V, Storch U, Dubrovska G,ObstM, YildirimE, Salanova B, Kalwa H, Essin K, Pinkenburg O, Luft FC,Gudermann T, Birnbaumer L: Increased vascular smoothmuscle contractility in TRPC6-/-mice. Mol Cell Biol 25: 6980-6989, 2005
21. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I: Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 6: 499-506, 2004
22. Hoffmann S, Podlich D, Hähnel B, Kriz W, Gretz N: Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 15: 1475-1487, 2004
23. Delles C, Jacobi J, John S, Fleischmann I, Schmieder RE: Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Kidney Int 61: 1462-1468, 2002
24. Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS: The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney Int Suppl 57: S132-S136, 1996
25. Takasaki J, Saito T, Taniguchi M, Kawasaki T, Moritani Y, Hayashi K, Kobori M: A novel Galphaq/11-selective inhibitor. J Biol Chem 279: 47438-47445, 2004
26. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS: Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 63: 641-683, 2011
27. North RA: Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067, 2002
28. North RA, Surprenant A: Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40: 563-580, 2000
29. Chung WC, Kermode JC: Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits. J Pharmacol Exp Ther 313: 191-198, 2005
30. Balazs B, Danko T, Kovacs G, Koles L, Hediger MA, Zsembery A: Investigation of the inhibitory effects of the benzoDiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods. Cell Physiol Biochem 32: 11-24, 2013
31. Mollet G, Ratelade J, BoyerO,Muda AO,Morisset L, Lavin TA, Kitzis D, DallmanMJ, Bugeon L,HubnerN, GublerMC, Antignac C, Esquivel EL: Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome. J AmSocNephrol 20: 2181-2189, 2009
32. Bernstein BW, Bamburg JR: Actin-ATP hydrolysis is a major energy drain for neurons. J Neurosci 23: 1-6, 2003
33. Ng YK, Lu X, Levitan ES: Physical mobilization of secretory vesicles facilitates neuropeptide release by nerve growth factor-differentiated PC12 cells. J Physiol 542: 395-402, 2002
34. Wang J, Richards DA: Spatial regulation of exocytic site and vesicle mobilization by the actin cytoskeleton. PLoS ONE 6: e29162, 2011
35. Bubb MR, Spector I, Beyer BB, Fosen KM: Effects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J Biol Chem 275: 5163-5170, 2000
36. Ou GS, Chen ZL, Yuan M: Jasplakinolide reversibly disrupts actin filaments in suspension-cultured tobacco BY-2 cells. Protoplasma 219: 168-175, 2002
37. Coward RJ, Welsh GI, Koziell A, Hussain S, Lennon R, Ni L, Tavaré JM, Mathieson PW, Saleem MA: Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56: 1127-1135, 2007
38. LangT:SNAREproteins and'membranerafts'. JPhysiol 585: 693-698, 2007
39. Orci L, Singh A, Amherdt M, Brown D, Perrelet A: Microheterogeneity of protein and sterol content in kidney podocyte membrane. Nature 293: 646-647, 1981
40. Fornoni A, Merscher S, Kopp JB: Lipid biology of the podocyte-new perspectives offer new opportunities. Nat Rev Nephrol 10: 379-388, 2014
41. Li J, Fountain SJ: Fluvastatin suppresses native and recombinant human P2X4 receptor function. Purinergic Signal 8: 311-316, 2012
42. Schermer B, Benzing T: Lipid-protein interactions along the slit diaphragm of podocytes. J Am Soc Nephrol 20: 473-478, 2009
43. Bugeon L, Danou A, Carpentier D, Langridge P, Syed N, Dallman MJ: Inducible gene silencing in podocytes: A new tool for studying glomerular function. J AmSoc Nephrol 14: 786-791, 2003
44. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P: Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17: 428-437, 2007
45. Mathieson PW: Podocyte actin in health, disease and treatment. Nephrol Dial Transplant 25: 1772-1773, 2010
46. Endlich N, Endlich K: Stretch, tension and adhesion-adaptive mechanisms of the actin cytoskeleton in podocytes. Eur J Cell Biol 85: 229-234, 2006
47. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K: Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 12: 413-422, 2001
48. Machuca E, Benoit G, Antignac C: Genetics of nephrotic syndrome: Connecting molecular genetics to podocyte physiology. Hum Mol Genet 18[R2]: R185-R194, 2009
49. Wilson C, Dryer SE: A mutation in TRPC6 channels abolishes their activation by hypoosmotic stretch but does not affect activation by diacylglycerol or G protein signaling cascades. Am J Physiol Renal Physiol 306: F1018-F1025, 2014
50. Roshanravan H, Dryer SE: ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: Role of podocin and reactive oxygen species. Am J Physiol Renal Physiol 306: F1088-F1097, 2014
51. Kessler S, Clauss WG, Fronius M: Laminar shear stress modulates the activity of heterologously expressed P2X(4) receptors. BiochimBiophys Acta 1808: 2488-2495, 2011
52. Yamamoto K, Korenaga R, Kamiya A, Ando J: Fluid shear stress activates Ca(2+) influx into human endothelial cells via P2X4 purinoceptors. Circ Res 87: 385-391, 2000
53. Pfeiffer ZA, Aga M, Prabhu U, Watters JJ, Hall DJ, Bertics PJ: The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264. 7 macrophages via p38 MAP kinase and Rho. J Leukoc Biol 75: 1173-1182, 2004
54. Pubill D, Dayanithi G, Siatka C, Andrés M, DufourMN, Guillon G, Mendre C: ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors. Cell Calcium 29: 299-309, 2001
55. Mundel P, Reiser J, Kriz W: Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 8: 697-705, 1997
56. Schlondorff D: Preparation and study of isolated glomeruli. Methods Enzymol 191: 130-140, 1990
57. Kalwa H, Storch U, Demleitner J, Fiedler S, Mayer T, Kannler M, FahlbuschM, Barth H, Smrcka A, Hildebrandt F, Gudermann T, Dietrich A: Phospholipase C epsilon (PLC) induced TRPC6 activation: a common but redundant mechanism in primary podocytes. J Cell Physiol 230: 1389-1399, 2015
58. Storch U, Forst AL, Philipp M, Gudermann T, Mederos y Schnitzler M: Transient receptor potential channel 1 (TRPC1) reduces calcium permeability in heteromeric channel complexes. J Biol Chem 287: 3530-3540, 2012
59. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985
60. Corriden R, Insel PA, Junger WG: A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells. Am J Physiol Cell Physiol 293: C1420-C1425, 2007